Robert S, Michael Gottlieb S, Robert S, Howard Schanker M, Joel D, Weisman DO, Peng Thim F, Robert Wolf A, Andrew S: Pneumocystis carinii Pneumonia and Mucosal Candidiasis in Previously Healthy Homosexual Men — Evidence of a New Acquired Cellular Immunodeficiency. N Engl J Med. 1981, 305: 1425-1431. 10.1056/NEJM198112103052401.
Article
Google Scholar
Barre-Sinoussi F, et al.: Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983, 220: 868-871. 10.1126/science.6189183.
Article
CAS
PubMed
Google Scholar
Hemelaar J, Gouws E, Ghys PD, Osmanov S: Global trends in molecular epidemiology of HIV-1 during 2000–2007. AIDS. 2011, 25: 679-689. 10.1097/QAD.0b013e328342ff93.
Article
PubMed Central
PubMed
Google Scholar
Thomson MM, Perez-Alvarez L, Najera R: Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis. 2002, 2: 461-471. 10.1016/S1473-3099(02)00343-2.
Article
CAS
PubMed
Google Scholar
Gilks CF, Crowley S, Ekpini R, et al.: The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 2006, 368 (9534): 505-510. 10.1016/S0140-6736(06)69158-7.
Article
PubMed
Google Scholar
World Health Organization: Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006, WHO, HIV Department, Geneva, Switzerland, Available at:http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf. Accessed 12 December 2007,
Google Scholar
Gazzard BG, British HIV: Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med. 2008, 9: 563-608. 10.1111/j.1468-1293.2008.00636.x.
Article
CAS
PubMed
Google Scholar
Vergne L, Peeters M, Mpoudi-Ngole E, Bourgeois A, Liegeois F, Toure-Kane C, Mboup S, Mulanga-Kabeya C, Saman E, Jourdan J, Reynes J, Delaporte E: Genetic diversity of protease and reverse transcriptase sequences in non-subtype B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients. J Cardiovasc Manag. 2000, 38: 3919-3925.
CAS
Google Scholar
Guide d’utilisation des Antirétroviraux (ARV) chez l’adulte et l’adolescent en République de DJIBOUTI: 2008,http://www.aidstar-one.com/sites/default/files/treatment/national_treatment_guidelines/Djibouti_adult_guidelines_2008.pdf,
Jlizi A, Ben Ammar A, El Gaaied A, Slim F, Tebourski M, Ben Mamou T, Ben C, et al.: Profile of drug resistance mutations among HIV-1-infected Tunisian subjects failing antiretroviral therapy. Arch Virol. 2008, 153: 1103-1108. 10.1007/s00705-008-0104-z.
Article
CAS
PubMed
Google Scholar
Abecasis AB, Vandamme AM, Lemey P: Quantifying differences in the tempo of human immunodeficiency virus type 1 subtype evolution. J Virol. 2009, 83: 12917-12924. 10.1128/JVI.01022-09.
Article
PubMed Central
CAS
PubMed
Google Scholar
Nyombi BM, et al.: Diversity of human immunodeficiency virus type 1 subtypes in Kagera and Kilimanjaro regions Tanzania. AIDS Res Hum Retroviruses. 2008, 24: 761-769. 10.1089/aid.2007.0311.
Article
CAS
PubMed
Google Scholar
Abebe A, Lukashov VV, Pollakis G, Kliphuis A, Fontanet AL, Goudsmit J, Rinke TF, de Wit TF: Timing of the HIV-1 subtype C epidemic in Ethiopia based on early virus strains and subsequent virus diversification. AIDS. 2001, 15: 1555-1561. 10.1097/00002030-200108170-00013.
Article
CAS
PubMed
Google Scholar
Abebe A, Lukashov VV, Rinke De Wit TF, Fisseha B, Tegbaru B, Kliphuis A, Tesfaye G, Negassa H, Fontanet AL, Goudsmit J, Pollakis G: Timing of the introduction into Ethiopia of subcluster C′ of HIV type 1 subtype C. AIDS Res Hum Retrovir. 2001, 17: 657-661. 10.1089/088922201300119770.
Article
CAS
PubMed
Google Scholar
Maslin J, Rogier C, Caron M, Grandadam M, Koeck JL, Nicand E: Antiretroviral drug resistance among drug-naive HIV-1-infected individuals in Djibouti (Horn of Africa). Antivir Ther. 2005, 10: 855-859.
CAS
PubMed
Google Scholar
Maslin J, Rogier C, Berger F, Khamil MA, Mattera D, Grandadam M, Caron M, Nicand E: Epidemiology and genetic characterization of HIV-1 isolates in the general population of djibouti (Horn of Africa). J Acquir Immune Defic Syndr. 2005, 39: 129-132.
PubMed
Google Scholar
Faria NR, Suchard MA, Abecasis A, Sousa JD, Ndembi N, Bonfim I, Camacho RJ, Vandamme AM, Lemey P: Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon. Infect Genet Evol. 2012, 12 (2): 453-460. 10.1016/j.meegid.2011.04.028.
Article
PubMed
Google Scholar
Hemelaar J, et al.: The origin and diversity of the HIV-1 pandemic. Trends in Molecular Medicine. 2011, 20: 1-11.
Google Scholar
Carr JK, Salminen MO, Albert J, Sanders-Buell E, Gotte D, Birx DL, McCutchan FE: Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. Virology. 1998, 247: 22-31. 10.1006/viro.1998.9211.
Article
CAS
PubMed
Google Scholar
Cornelissen M, van Den Burg R, Zorgdrager F, Goudsmit J: Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa. J Gen Virol. 2000, 81: 515-523.
Article
CAS
PubMed
Google Scholar
Rousseau CM, Learn GH, Bhattacharya T, Nickle DC, Heckerman D, Senica C, Christian B, Philip J, Goulder R, Bruce D, Walker Photini K, Korber BT, Mullins JI: Extensive Intra-subtype Recombination in South African HIV-1 Subtype C Infections. J Virol. 2007, 81 (9): 4492-4500. 10.1128/JVI.02050-06.
Article
PubMed Central
CAS
PubMed
Google Scholar
Darar HY, Kibangou N, Mbuzenakamwe MJ, Goulan MA, Ibrahim IM: Réponse au traitement antirétroviral chez les patients infectés par le VIH-1 suivis au Centre Yonis Toussaint de Djibouti [Abstract]. 5éme Conférence Francophone VIH/SIDA, Maroc. 2010, 493 (77): 215-28–31 March 2010
Google Scholar
Kibangou N: Prise en charge des patients sous traitement ARV à Djibouti entre 2004 et 2009 [Abstract]. 5éme Conférence Francophone VIH/SIDA, Maroc. 2010, 578 (88): 237-28–31 March 2010
Google Scholar
Johnson VA, Vincent C, Günthard HF, Roger P, Deenan P, Robert S, Wensing AM, Richman DD: 2011 update of the drug resistance mutations in HIV-1. Top Antivir Med. 2011, 19: 156-164.
PubMed
Google Scholar
Geretti AM: Clinical implications of HIV drug resistance to nucleoside and nucleotide reverse transcriptase inhibitors. AIDS Rev. 2006, 8: 210-220.
PubMed
Google Scholar
Theys K, Deforche K, Libin P, Camacho RJ, Van Laethem K, Vandamme AM: Resistance pathways of human immunodeficiency virus type 1 against the combination of zidovudine and lamivudine. J Gen Virol. 2010, 91: 1898-1908. 10.1099/vir.0.022657-0.
Article
CAS
PubMed
Google Scholar
Van Vaerenbergh K, Van Laethem K, Albert J, Boucher CA, Clotet B, Floridia M, Gerstoft J, Hejdeman B, Nielsen C, Pannecouque C, Perrin L, Pirillo MF, Ruiz L, Schmit JC, Schneider F, Schoolmeester A, Schuurman R, Stellbrink HJ, Stuyver L, Van Lunzen J, Van Remoortel B, Van Wijngaerden E, Vella S, Witvrouw M, Yerly S, De Clercq E, Destmyer J, Vandamme AM: Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues. Antimicrob Agents Chemother. 2000, 44: 2109-2117. 10.1128/AAC.44.8.2109-2117.2000.
Article
PubMed Central
CAS
PubMed
Google Scholar
Coakley EP, Gillis JM, Hammer SM: Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine. AIDS. 2000, 14: F9-F15. 10.1097/00002030-200001280-00002.
Article
CAS
PubMed
Google Scholar
Shafer RW: Genotypic testing for human immunodeficiency virus type 1 drug resistance. Clin Microbiol Rev. 2002, 15: 247-277. 10.1128/CMR.15.2.247-277.2002.
Article
PubMed Central
CAS
PubMed
Google Scholar
Emanuele B, Ana PC M, Victor Moreschi N, Camila DA S, Karla A, Saito AO, Mecatti MC, Santos MG, Pimentel CR, Larissa LG S, Cruz CR, de Noronha L: Histomorphometric and immunohistochemical analysis of infectious agents, T-cell subpopulations and inflammatory adhesion molecules in placentas from HIV-seropositive pregnant women. Diagn Pathol. 2011, 6 (101): 101-24 October 2011
Google Scholar
Eholie SP, N’Dour CT, Cisse M, Bissagnene E, Girard PM: Observance of antiretroviral treatments African specificities. Med Mal Infect. 2006, 36: 443-448. 10.1016/j.medmal.2006.07.019.
Article
PubMed
Google Scholar
Phillips AN, Dunn D, Sabin C, et al.: UK Collaborative Group on HIV Drug Resistance, UK CHIC Study Group. Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice. AIDS. 2005, 19: 487-494.
Article
PubMed
Google Scholar
Chesney MA, Ickovics J, Hecht FM, et al.: Adherence: a necessity for successful HIV combination therapy. AIDS. 1999, 13 (A): S271-S278.
PubMed
Google Scholar
Bangsberg DR, Charlebois ED, Grant RM, et al.: High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS. 2003, 17: 1925-1932. 10.1097/00002030-200309050-00011.
Article
PubMed
Google Scholar
Shah B, Walshe L, Saple DG, et al.: Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clin Infect Dis. 2007, 44: 1235-1244. 10.1086/513429.
Article
PubMed
Google Scholar
Ahmed AA, Katlama C, Ghosn J, Guiguet M, Costagliola D: Évaluation de l’observance au traitement antirétroviral au sein d’une cohorte de 200 patients à Djibouti (2005). Eastern Mediterranean Health Journal. 2007, 13 (6): 1286-1297.
CAS
PubMed
Google Scholar
Renoux E, Barreh Matan A, Sevre JP, et al.: Tuberculose et infection VIH: expérience du programme national de lutte antituberculeuse de Djibouti: 1990–1996. Med Trop. 2002, 62: 171-176.
CAS
Google Scholar
Acina E, Morand C, Mahdi A, Morand JJ: La malnutrition en République de Djibouti: un problème majeur de santé publique. Revue de l’ISERST. 1991, 5: 11-15.
Google Scholar
Little SJ, Holte S, Routy JP, et al.: Antiretroviral-drug resistance among patients recently infected with HIV. New Engl J Med. 2002, 347: 385-394. 10.1056/NEJMoa013552.
Article
CAS
PubMed
Google Scholar